Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics.
about
Multilevel modeling and value of information in clinical trial decision support.Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.Quantitative benefit-harm assessment for setting research priorities: the example of roflumilast for patients with COPDValue of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An IllustrationSquaring the circle: a priority-setting method for evidence-based service development, reconciling research with multiple stakeholder views.Improving early cycle economic evaluation of diagnostic technologies.Interpretation of the Expected Value of Perfect Information and Research Recommendations: A Systematic Review and Empirical Investigation.Are Evidence Standards Different for Genomic- vs. Clinical-Based Precision Medicine? A Quantitative Analysis of Individualized Warfarin Therapy.Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research.The premarket assessment of the cost-effectiveness of a predictive technology "Straticyte™" for the early detection of oral cancer: a decision analytic modelValue of Information: A Tool to Improve Research Prioritization and Reduce Waste.Adjusting Estimates of the Expected Value of Information for Implementation: Theoretical Framework and Practical Application.Burden of illness and research investments in translational sciences for pharmaceuticals in metastatic cancers.
P2860
Q35006548-04685149-B6B3-4F5D-836F-46878384D739Q35681121-B9893E4C-1200-4FC7-A719-0CEAD80EC06BQ35681671-313D187E-3FD9-4E82-BEE2-D3F88C646F44Q35683100-3E349E61-1817-4E3F-9F02-AC74EDF0EB55Q35743150-76BF7EC5-11BA-41EB-9FE4-2C4A6F3470D9Q38207115-8FD729EA-4070-4B31-8652-9018762ABC0DQ38489282-F6D41C07-A5AB-431C-9783-3684429D5D35Q38758788-5F83F58B-7F9A-4945-BBA5-A5BB877A1E16Q38890570-CAD2CABC-0B94-4FD6-9F90-A4B715F828F7Q38981381-905AE1ED-3DAA-45FF-A623-39371EAEED18Q42369053-04A49967-1AB2-4B6C-BAB3-622D454E5E70Q43236695-05D4993E-7050-48F1-A942-F58DCFEB7A57Q53284749-6B7F8179-FD79-43C7-9630-A879F203E9D5Q54378047-A219C7BF-E881-43B1-9544-B60B05335DFD
P2860
Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Value-of-information analysis ...... pplication in cancer genomics.
@en
Value-of-information analysis ...... pplication in cancer genomics.
@nl
type
label
Value-of-information analysis ...... pplication in cancer genomics.
@en
Value-of-information analysis ...... pplication in cancer genomics.
@nl
prefLabel
Value-of-information analysis ...... pplication in cancer genomics.
@en
Value-of-information analysis ...... pplication in cancer genomics.
@nl
P2093
P2860
P356
P1476
Value-of-information analysis ...... pplication in cancer genomics.
@en
P2093
David L Veenstra
Josh J Carlson
Julie Gralow
Laura Esmail
Laurence Baker
N Lynn Henry
Pat Deverka
Rahber Thariani
Scott D Ramsey
P2860
P304
P356
10.1177/0272989X13484388
P577
2013-05-01T00:00:00Z